Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapies of HDAC inhibitors and PD-L1 inhibitors

Combination therapies of HDAC inhibitors and PD-L1 inhibitors

US Patent 10385131 · Granted Aug 20, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulcardine administration for treatment of acute atrial fibrillation2025
Modular mast2025
SHP2 inhibitor monotherapy and uses thereof2025
Modular concrete foundation2025
Combination therapies of HDAC inhibitors and PD-1 inhibitors2024
Combination therapies of HDAC inhibitors and PD-1 inhibitors2024
Combination therapies of HDAC inhibitors and PD-1 inhibitors2024
Combination therapies comprising SHP2 inhibitors and PD-1 inhibitors2024
Sulcardine administration for treatment of acute atrial fibrillation2023
Charging station for an electric vehicle2023
Combination therapies of HDAC inhibitors and PD-L1 inhibitors2022
Combination therapies of HDAC inhibitors and PD-L1 inhibitors2022